Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Research Area(s) / Expertise:

Electrophysiology & Arrhythmia

Atrial Fibrillation

Job title: Medical Director
Dr Osorio is the director of electrophysiology at Grandview Medical Center in Birmingham, AL, US.Dr JoseOsorio completed training at the University of Alabama at Birmingham in Cardiovascular Disease and Clinical Cardiac Electrophysiology. Followinghis training, he served as an Assistant Professor at UAB for 3 years and was the Director of Electrophysiology and the Catheterization Laboratory at… View more
Author(s): Giulio Falasconi Added: 1 year ago
EHRA 24 - In this video, investigator, Dr Giulio Falasconi (Humanitas Research Hospital, IT) joins us to discuss the findings from the QDOT-by-LAWT trial. This study included 162 patients with paroxysmal atrial fibrillation not responding to antiarrhythmic drugs. They were retrospectively enrolled and randomized on a 1:1 basis to the QDOT-by-LAWT study group, and the control group.Findings showed… View more
Research Area(s) / Expertise: Job title: Electrophysiologist
Prof Gabor Széplaki is an electrophysiologist at Mater Private Hospital, Dublin, Ireland. He graduated as an MD at the Semmelweis University, Budapest and later completed his PhD thesis in the field of atherosclerosis.He completed his cardiology training and later worked as a senior lecturer at the Heart and Vascular Centre, Semmelweis University before joining the Mater Private Hospital.He also… View more
Job title: Assistant Professor of Radiology
Author(s): Daniel Scherr Added: 1 year ago
AF Symposium 25 - The MANIFEST-REDO sub-study suggests repeat ablation procedures due to clinical recurrence of atrial fibrillation (AF) can be performed safely and with an acceptable success rate.Prof Daniel Scherr (Medical University, Graz, AT) joins us onsite at AF Symposium 25 to discuss the insights from MANIFEST-REDO, investigating repeated ablation following pulmonary vein isolation (PVI)… View more
Added: 2 years ago Source:  AF Symposium
AUTHOR: Greg Guillory, Jordan RanceThe AF symposium has announced two late-breaking clinical trial sessions set to be presented in Boston from February 1st to February 3rd this year. The AF symposium is dedicated to bringing together the world’s leading scientists to share the latest advances in atrial fibrillation.Thursday 1st February 2024Late Breaking Clinical Science Session I6:00 – 7… View more
Added: 4 months ago Source:  Arrhythmia Academy
For patients undergoing atrial fibrillation (AF) ablation, preprocedural thrombus screening with intracardiac echocardiography (ICE) is noninferior to the standard transoesophageal echocardiography (TEE) for preventing thromboembolic events, according to findings from a recent randomised trial.¹ The study, known as the ICE vs TEE Study (NCT05466266), also found that ICE offered benefits in… View more
Added: 3 months ago Source:  Radcliffe Cardiology
A novel nanosecond pulsed field ablation (nsPFA) system has demonstrated noninferior efficacy and comparable safety to conventional ablation index (AI)-guided radiofrequency ablation (RFA) for treating paroxysmal atrial fibrillation (AF), according to results from the InsightPFA trial.¹ The study also highlights that the procedure can be performed under conscious sedation, potentially… View more
Research Area(s) / Expertise:

Atrial Fibrillation

Electrophysiology & Arrhythmia

Atrial Arrhythmias

Personal History Dr Joseph Gabriel Akar was born in January 1971 and speaks Arabic, English and French.9 He is an Associate Professor of Medicine in the Section of Cardiology at the Yale University School of Medicine. He is currently Chief of Cardiac Electrophysiology and Director of the Electrophysiology Laboratory and the Complex Ablation Program at Yale-New Haven Hospital. … View more